a n a LY S i S Next-generation sequencing (NGS) technologies have fueled genetic research and provided unprecedented means of building an increasingly comprehensive catalog of single-nucleotide variants (SNVs), small indels and structural variants. Although cataloging these kinds of common events has continued at a brisk pace, there has been little progress in the discovery of complex indels after the transition from Sanger sequencing to NGS technologies.
In 2007, the first diploid genome was sequenced using Sanger dideoxy technology, revealing thousands of complex germline indels 1 .
Complex insertions and deletions (indels) are formed by simultaneously deleting and inserting DNA fragments of different sizes at a common genomic location. Here we present a systematic analysis of somatic complex indels in the coding sequences of samples from over 8,000 cancer cases using Pindel-C. We discovered 285 complex indels in cancerassociated genes (such as PIK3R1, TP53, ARID1A, GATA3 and KMT2D) in approximately 3.5% of cases analyzed; nearly all instances of complex indels were overlooked (81.1%) or misannotated (17.6%) in previous reports of 2,199 samples. In-frame complex indels are enriched in PIK3R1 and EGFR, whereas frameshifts are prevalent in VHL, GATA3, TP53, ARID1A, PTEN and ATRX. Furthermore, complex indels display strong tissue specificity (such as VHL in kidney cancer samples and GATA3 in breast cancer samples). Finally, structural analyses support findings of previously missed, but potentially druggable, mutations in the EGFR, MET and KIT oncogenes. This study indicates the critical importance of improving complex indel discovery and interpretation in medical research.
The 1000 Genomes Project recently reported 664 germline complex indels in Corriell sample NA12878 (ref. 2) . In the Genome of the Netherlands project, 291 de novo indels were discovered, of which 14 (4.8%) were complex indels 3 . Roerink et al. 4 reported complex indels in Caenorhabditis elegans strains lacking translesion synthesis polymerases. More recently, this group found that a G-quadruplex structure induced mutagenesis that was characterized by the occasional presence of template insertions 5 . A synthesis-dependent microhomology-mediated end joining (SD-MMEJ) model was proposed to explain the indel formation mechanism 6 . Using traditional technologies, complex indels have also been detected in individuals with cancer. For example, to detect deletions in exon 19 of EGFR, the gene encoding the epidermal growth factor receptor, a fragmentlength analysis was first performed to select potential carriers, and then the entire exon 19 of EGFR was PCR-amplified and sequenced on an Applied Biosystems (ABI) sequencer [7] [8] [9] .
Since the introduction of NGS instruments, searching for complex indels has mostly been neglected owing to the lack of effective tools for mapping and detecting complex indels in short sequence reads. We are aware of one report describing the discovery of three somatic complex indels within the gene encoding calreticulin (CALR) in cancer samples using NGS 10 . We scanned the published mutation annotation files (MAFs) from ten cancer project papers published by The Cancer Genome Atlas (TCGA) [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] and found a complex indel in the FMS-like tyrosine kinase 3 (FLT3) gene in samples from individuals with acute myeloid leukemia (AML), and complex indels in five genes associated with ovarian cancer (OV)-namely, CNGA1, CCDC136, MFAP3L, SLC13A1 and TP53. Here we report an algorithm for systematically detecting complex indels from NGS data. Our analysis reveals an unexpected prevalence of these events in human cancer, the potential mechanisms underlying the formation of complex indels and their effect on gene function. Finally, we highlight the discovery of clinically relevant complex indels and their impact on treatment strategies.
RESULTS

Implementation of Pindel-C and performance evaluation
We developed a novel module within the Pindel algorithm, which we refer to as Pindel-C, to specifically search for co-occurring insertion and deletion events, namely complex indels (Fig. 1a) (see Online Methods). We examined the sensitivity and specificity of Pindel-C a n a LY S i S 9 8 VOLUME 22 | NUMBER 1 | JANUARY 2016 nature medicine using three data sets. First, we randomly generated a 10-Mbp reference genome. Then we simulated the presence of 1,000 complex indels, with deletion and insertion sizes ranging from 1-1,000 bp. In addition, we generated two sets of 30× coverage with distinct read lengths and insert sizes and used the alignment algorithms BWA-aln and BWA-mem (see Online Methods). In general, the larger insertions could be detected with longer reads, although the power to detect deletions is rather consistent (Supplementary Fig. 1 ). When the read length was increased from 100 bp to 250 bp and BWA-aln was applied, the maximum insertion size we detected changed from 69 bp to 218 bp. For complex indels within the detection limit of the read length (see Online Methods), we observed 87.93% sensitivity for a read length of 100 bp and 70% sensitivity for a read length of 250 bp. We found that overall performance of Pindel-C was better on BWA-aln-produced BAM files than on BWA-mem-produced BAM files (Supplementary Fig. 1 ). Second, we introduced 1,128 synthetic complex indels on chromosome 1 of a standard genome reference sequence 1 (HuRef GCA_000002125.2) and simulated 100× Illumina paired-end data (Online Methods and Supplementary Table 1) . Pindel-C detected 541 of them (48% sensitivity) (Supplementary Table 2 ), whereas neither the Genome Analysis Toolkit (GATK) nor the 'variant detection in massively parallel sequencing data' (VarScan) software program detected any correctly (Online Methods). The latter two are standard bioinformatics tools, although neither is tuned specifically to identify complex indels. Pindel-C miscalled 88 events as simple indels, suggesting a false discovery rate (FDR) of about 14% (Fig. 1b) . We found that the detection sensitivity dropped dramatically as the sizes of the deletions and insertions increased, which is largely expected for short-read data (Supplementary Fig. 2) .
Third, we experimentally examined the performance of Pindel-C in detecting complex indels in using data from the COLO 829 melanoma cell line. Specifically, we applied it to 40× data of COLO 829 melanoma cells (cell line CRL-1974 from the American Type Culture Collection (ATCC)) and 32× coverage data of the Epstein-Barr virustransformed control B lymphoblast cells from the same individual (cell line CRL-1980 from the ATCC) reported by Pleasance et al. 21 ; after automated filtering, we obtained 17 somatic and 2,213 germline complex indels. A total of 75 events (the 17 somatic and 58 randomly selected germline complex indels) were selected for experimental validation (Online Methods). We successfully obtained PCR products and Sanger-sequencing data for 51 of them (12 somatic and 39 germline complex indels). Our subsequent analysis demonstrated validation rates for somatic and germline events of 75% (9 of 12) and 100% (39 of 39), respectively. It is worth noting that the CRL-1974 batch we purchased from the ATCC was not the same as the one sequenced by Pleasance et al. 21 ; therefore, the three somatic complex indels detected in the original sequencing data may not be present in our validation cell line (Supplementary Table 3 and Supplementary Notes 1-3) . This exercise indicates the need for purpose-designed software, as complex indels present unique challenges for detection.
Exome-wide landscape of complex indels To obtain a more global view on complex indels across the entire coding sequence, we processed 8,060 tumor and matched-normal sample pairs across 22 cancer types. Our initial analysis showed that excessive numbers of apparently somatic complex indels in some samples were actually attributable to sequence artifacts regardless of genomic The inset (left) shows three basic configurations as pseudo-de Bruijn graphs (in which the circular or diamond loops represent sequences that were removed to obtain alignment): a simple deletion (top), a complex indel with a template sequence from the 5′ sense strand (middle) and a complex indel with a template sequence of the reverse complement to the deleted fragment (bottom location (such as 1-bp indels at fixed-read positions). This observation prompted a quality-control (QC) examination of the BAM files to compute the percentage of reads that carried such sequence artifacts for each sample (Online Methods). A histogram of these percentages ( Supplementary Fig. 3 ) suggested a 20% threshold for removing BAM files enriched with read artifacts (Online Methods). The remaining 4,742 samples were then deemed suitable for exome-wide analysis. Among these 4,742 samples, Pindel-C predicted 2,948 raw somatic complex indels with a variant-allele fraction (VAF) greater than 10%. We manually reviewed all of them using the integrative genomics viewer (IGV) 22 and identified 1,680 predictions with read support from both strands (Supplementary Table 4) . It is expected that the number of complex indels in coding regions is generally low (Fig. 2a) , although there were a few samples with substantially more instances of complex indels in coding regions. We investigated the genes that could contribute to these elevated numbers using the 'mutational significance in cancer' (MuSiC) software 23 (Online Methods) but did not detect any substantial correlation (Supplementary Table 5 ). Whole-genome sequencing data will be required to obtain accurate complex indel-mutation frequencies across sample sets.
We annotated the translational effects of 1,680 putative somatic complex indels and examined which genes were frequently affected by somatic complex indels (Online Methods). We noticed that 895 samples harbored one or more complex indels from 1,493 genes. Notably, the most frequently affected genes are well-known cancer genes. For example, 15 somatic complex indels were detected in PIK3R1. Other top-ranked genes were TP53, ARID1A, GATA3 and KMT2D (Fig. 2b) . This result suggests that somatic complex indels in cancer genes are probably under positive selection during tumorigenesis.
We also evaluated the lengths of these 1,680 somatic complex indels and found that deleted sequences are generally longer, but that there is no obvious correlation between the lengths of the deletions and insertions. We observed that insertion frequency decreases as insertion size increases; the proportions for 1-bp, 2-bp and 3-bp insertions are 58.7%, 20.4% and 8.9%, respectively. Additionally, we found that the majority of deletions are 2-bp long (41.3%), whereas 1-bp and 3-bp deletions occur at frequencies of 8.8% and 18.8%, respectively (Fig. 2c) .
Frequency and mechanism of complex indels in cancer genes
To overcome the effects of the sequencing artifacts discussed above, we used a multistep strategy of initial discovery, manual review, regenotyping, and DNA sequencing-and RNA sequencing (RNA-seq)-based validation to curate a high-confidence, comprehensive set of complex indels across the entire 8,060-sample set.
We compiled a list of 624 cancer genes from the literature [24] [25] [26] [27] [28] [29] [30] [31] (Online Methods and Supplementary Table 6 ) and found that 140 of these harbor 285 somatic complex indels in the samples analyzed (Supplementary Table 7 ). We examined whole-genome and RNAseq data that were generated within TCGA for the sites we identified and found that these sites are mostly supported if coverage is reasonably high (Supplementary Table 8 and Supplementary Notes 1-3). We examined local alignments around the breakpoints, cross-checked them against TCGA reports [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] and found that 13 of these indels were previously reported as substitutions, despite adjacent gapped alignments in the primary alignment result. Notably, 83 of them are within 100 bp of another complex event, indicating nonrandom distribution (by using the geometric probability test; see Online Methods). We argue that the local sequence context may be prone to double-stranded DNA breaks or may be under selection for a cancer phenotype, thus elevating the likelihood of generating complex indels. Alternatively, it is possible that the critical spots to disturb or activate key cancer genes are rather limited and that these events are under selection for enrichment. From the set of well-curated complex indels in cancer genes, we attempted to further search for the origins of the inserted sequences. Because the inserted sequences are relatively short, we searched the local, flanking 50-bp sequences for similarities with insertions greater than 4 bp. This explained 32 of the complex indels. We propose a classification scheme (Fig. 3) consisting of 12 different classes on the basis of the indels detected among the 32 sites. Direct and reverse copies of the 5′ or 3′ flanking sequences were the most common classes, representing 37.5% and 31.3% of the complex indels, respectively. Those single direct or inverted copies of short fragments of flanking sequences were considered to be instances of loop-out and snap-back SD-MMEJ, a model that was originally proposed on the basis of a study in C. elegans 6 . In addition, we also discovered that one-third of the template insertions originated from various combinations of two origins (Fig. 3) . In the mechanism illustrated by 'Ref R' and '5R' (Fig. 3) , part of the deleted sequence is inserted as a reverse complement plus a reverse-complementary copy of the 5′ flanking sequence. All 12 formation mechanisms were observed in these 32 somatic complex indels. Other mechanisms might be discovered with additional samples or whole-genome sequences. We observed 21 genes (ALK, APC, ARHGAP35, ARID1A, ATRX,  EGFR, EPHA2, FAT1, GATA3, KEAP1, LRP1B, MAP3K1, MET, NF1,  PBRM1, PIK3R1 , PTEN, RB1, SETD2, TP53 and VHL) with complex indels in at least three cancer samples. The majority of these genes (17 of 21) encode tumor suppressors. PIK3R1 ranks first, with 20 mutations, 16 of which are in uterine corpus endometrial carcinoma (UCEC) samples. More than half of these result in in-frame mutations, which is consistent with the in-frame simple indels more typically found in this gene. The next four most frequently mutated genes (TP53, ARID1A, PTEN and ATRX) are not specific to one cancer type. Among the most frequently mutated 21 genes, there are only three oncogenes (EGFR, ALK and MET) that harbor somatic complex indels. Functionally, 8 of the 21 genes (PIK3R1, TP53, PTEN, FAT1, RB1, APC, ALK and MAP3K1) are related to the processes of cell growth, differentiation, proliferation and movement. There are also five genes (EGFR, NF1, GATA3, MET and EPHA2) that encode components that are either transcription factors or involved in signal transduction pathways, four (ATRX, ARID1A, PBRM1 and SETD2) that encode factors related to chromatin structure, and three that are involved in either an energy or oxidant response.
Tissue specificity and functional features of complex indels
Some of the genes have cross-cancer relevance, e.g., somatic complex indels in TP53 appear in nine cancer types (Fig. 4) . Others show more specificity, such as the eight EGFR in-frame somatic complex 
5F and 3R 5F and 5R Because of the appearance of in-frame clusters within some cancer-gene combinations, we sought to determine whether any of these were more prevalent than at a frequency that could be explained by random chance. We calculated a background in-frame rate of about 0.103 from 1,680 exome-wide complex indels and used this as a Bernoulli estimator for hypothesis testing of in-frame versus frameshift indels using a binomial probability model (Online Methods). We found four groupings that were significant: EGFR in LUAD (FDR = 10 −7 ), PIK3R1 in multiple cancer types and in UCEC specifically (respective FDRs of 3 × 10 −7 and 2 × 10 −5 ), and TP53 in multiple cancers (FDR = 0.07). These observations are consistent with previous discoveries and underscore the importance of these three genes in tumorigenesis.
The seven events in VHL in KIRC were all frameshifts as expected, but this was not significant (P value = 0.47) with respect to the high background frameshift rate.
Timing of the emergence of complex indels VAFs of some somatic complex indels seemed to be higher than those of other simple forms of variants in the given samples (Supplementary Table 9 ). We sought to determine whether there were any cancer-gene combinations in which these differences were statistically significant (Online Methods). However, because the indel census is typically lower than that for SNVs, statistical power is a concern. In particular, the data show an average of five simple variants per complex indel for the samples we examined. In general, this rules out the testing of singletons in favor of combinations of samples from a given cancer type that has complex indels in the same gene. The exclusion process ultimately identified six cancer-gene combinations for testing ( Table 1) . After correcting for multiple tests, we found that EGFR in LUAD showed significantly higher VAF values for complex indels versus simple variants than did other genes (FDR ~4%), with the average VAF values differing here by almost 40%. Breast cancer (BRCA)-associated TP53 and KIRC-associated VHL mutations have VAF differences of 23% and ~10%, respectively, suggesting higher complex indel VAFs, but these did not reach significance. However, additional data would probably confirm the significance of BRCA-associated TP53 and KIRC-associated VHL mutations in comparison to VAF differences observed with KIRC-associated PBRM1. Specifically, the two KIRCassociated genes show comparable VAF differences, but the greater amount of data in KIRC-associated VHL increases statistical power with a P value of about half of that for KIRC-associated PBRM1, a trend that will probably continue to be observed for all three combinations with additional data. Conversely, the larger amount of data, coupled with a much smaller VAF difference for UCEC-associated PIK3R1 mutations, firmly indicates no considerable difference for complex versus simple indels.
Druggable complex indels supported by structure analysis
We also compared the numbers of newly discovered somatic complex indels with somatic simple indels in ten genes reported in TCGA project papers [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . These new indels increase the somatic indel census by 10%. Notably, for EGFR the census increased by 25% (Fig. 4b) . We also noticed that somatic complex indels are spatially distributed in tumor suppressor genes but concentrated within local regions in oncogenes. This phenomenon is not surprising because, given the wider availability of function-affecting locations, disrupting protein function is more probable. Conversely, activating a protein or boosting its intrinsic activity often requires a specific disturbance of the protein structure by adding or removing a few residues with in-frame variations. For example, in EGFR we detected four distinct somatic complex indels affecting amino acid residues 746-751, and two of them are recurrent (Fig. 5a,b) . We visualized the variants in the three-dimensional (3D) structure of EGFR (Protein Data Bank (PDB) 1M17) and found that all of them are on the flexible loop, which is part of the ATP-binding pocket. The EGFR inhibitor erlotinib is cocrystalized with EGFR in 1M17, and we noticed that erlotinib contacts the loop directly at sites that contain multiple somatic complex indels that we detected in our study. The four distinct somatic complex indels are coded by exon 19 of EGFR, and these indels removed six, four, six and eight amino acid residues of the loop, respectively. Consequently, we hypothesize that the functional impact of those mutations may be similar to the frequently occurring exon 19 deletion. If that is the case, then our newly discovered somatic EGFR complex indel mutants may also exhibit increased and sustained phosphorylation of EGFR and other ERBB-family proteins, thereby selectively activating the AKT and STAT signaling pathways that promote cell survival 32 . In addition, it has been reported that individuals with the exon 19 deletion respond well to treatment with erlotinib and gefitinib, with response rates >62% in various clinical trials (http://www.mycancergenome.org). We detected two in-frame complex indels ('Q556_E561delinsR' and 'I563_E572delinsRF' , as annotated by the variant effect predictor at http://www.ensembl.org/info/docs/tools/vep/) in the KIT oncogene from individuals in the TCGA data set who had sarcoma (SARC) and skin cutaneous melanoma (SKCM) cancers. Similarly to that observed in EGFR, the two KIT mutations also encode changes in the kinase domain and in the same loop region, as compared to EGFR, and these regions interact directly with the inhibitor PLX647 in the 3D structure of KIT (PDB 4HVS) (Fig. 5c,d ). Thus we hypothesize that these two in-frame complex indels may cause the kinase to be constitutively active. It has been reported that melanomas that are associated with most KIT mutations respond well to treatment with imatinib, sunitnib and sorafenib. Careful examination of the drug response results in cells with KIT mutations shows that our complex indels mostly overlap with the in-frame mutations del554-559 and del556-572, and thus KIT with these complex indels may also be sensitive to all three drugs.
DISCUSSION
The development and application of Pindel-C has led to the discovery of a substantial number of somatic complex indels that were overlooked by earlier studies [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , and many of these are likely to be driver mutations in the cancer samples from which they originated. Although the absolute numbers of such indels in an individual's genome might be smaller than those of somatic SNVs or simple indels, some complex indels are present at high VAFs in key cancer genes and originate in founding clones. These findings collectively suggest that the complex indel is an important factor in diseases like cancer than was previously appreciated.
This study used exome-sequencing data from various cancer types, which essentially precludes the discovery of indels outside of coding regions. We did not observe any large complex indels, although Pindel-C can, in principle, identify such events. Germline complex indels in cancer data are also mostly unexplored but worthy of further investigation.
We designed and implemented Pindel-C to detect somatic complex indels in cancer data. Our systematic QC identified a fraction of samples with sequence artifacts. To accurately obtain complex indels in an automated fashion, we omitted samples with an excessive number of sequence artifacts. The QC script and the automated variant-filtering procedure have been deposited at GitHub (see Online Methods). Our analysis of TCGA data identified several druggable mutations in EGFR and KIT with in-frame complex indels. In the era of precision medicine, it will be critical to capture all druggable mutations, including previously overlooked somatic druggable complex indels, in cancer patients.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper. a n a LY S i S ONLINE METHODS Data analyzed. We procured 8,060 samples from 22 distinct cancer types for our analysis. The largest cohort, BRCA, contains 990 samples and the smallest, kidney chromophobe (KICH), has 66 samples, with an average of 366 samples per cancer type (see Supplementary Note 4 for cancer cohort acronyms). All 8,060 samples have exome-sequence data from tumor and matchednormal, with average coverage above 100×. We curated the reported somatic indels from all previously published TCGA marker papers [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] and identified one complex indel in AML and five in ovarian cancer (OV). Those six somatic complex indels were initially discovered as simple variants but were revealed to be complex from Sanger-sequencing results.
BAM quality control for exome-wide analysis. In our preliminary runs of Pindel-C, we noticed excessive numbers (more than 10,000) of somatic complex indel calls in a subset of samples. Using IGV 22 we manually reviewed a random subset of those calls in ten offending samples and found specific sequence artifacts, including extensive soft clipping and alignment gaps at fixed positions of the reads, regardless of genomic position. We subsequently implemented a BAM QC script to identify such sequence artifacts. All reads were scanned individually to count the total number, as well as the number of reads carrying non-M characters in the Compact Idiosyncratic Gapped Alignment Report (CIGAR) string. We discarded BAM files if excessive numbers of indel-carrying reads (≥20%) were detected (Supplementary Fig. 1 ). The BAM QC script has been deposited at https://github.com/ding-lab/VariantQC and will be merged with Pindel-C later.
Simulation and sensitivity comparison. We simulated Illumina sequence data containing complex indels of a standard genome reference sequence (HuRef GCA_000002125.2) to test Pindel-C, GATK and VarScan for detection sensitivity. First, we examined the complex indel variants of the Venter genome (characterized with ~800-bp Sanger reads in the original discovery paper) on chromosome 1 and removed any that could be classified as simple indels or that resided within low-complexity regions. This step furnished 1,128 complex indels, which were then introduced into the chromosome 1 sequence of human build hg18 (Supplementary Table 1) . Then we used wgsim (http://github.com/ lh3/wgsim; v0.3.1-r13) to generate 100× Illumina paired-end synthetic sequence data, with 500-bp insert sizes and 100-bp read lengths. These sequence data were aligned with BWA (0.6.1-r104) using its paired-end module. This setting allows us to test whether a tool is able to capture complex indels at all, given sufficient coverage of data. Pindel-C (v0.2.5a7) was run with the same settings as those used for the exome-sequence data. We also ran VarScan (v2. Sanger-sequencing confirmation of complex indels. COLO 829 melanoma cells (CRL-1974) and the Epstein-Barr virus-transformed control B lymphoblast cells from the same individual (CRL-1980) were acquired from ATCC (Manassas, VA, USA) and cultured in RPMI-1640 medium supplemented with 10% FBS, 100 units/ml penicillin and 100 µg/ml streptomycin, at 37 °C in 5% CO 2 /95% air. DNA was purified from these cells using a mammalian genomic DNA extraction kit (Sigma-Aldrich, St. Louis, MO, USA; catalog number: G1N10-1KT). About 10 ng of genomic DNA was used for amplifying the genomic region containing the complex indel. PCR (50 µl) was done with Taq polymerase (Promega, Madison, WI, USA; catalog number: M8298) using the cycling conditions: 95 °C for 2 min; 35 cycles of (95 °C for 30 min, 45-52 °C for 30 min (annealing temperature depends on the melting temperature (T m ) of the primers used), 72 °C for 1 min); 1 cycle of 72 °C for 5 min. 10 µl of the PCR products was separated on a 2% agarose gel to check for the quality of the amplification. Reactions with robust and specific amplifications were purified by using a PCR product cleanup kit (Qiagen, Valencia, CA, USA; catalog number: 28104). 8-12 ng of the amplicons with a size range of 175-300 bp were bi-directionally sequenced by the Sanger method using the PCR primers. The presence or absence of the complex indels were determined by aligning the sequencing traces to the reference sequence and sequence contained the predicted indels.
MuSiC-based correlation analysis. We took the number of complex indels in a sample as the trait and the published somatic variants in the TCGA maf files as the source for our MuSiC correlation runs.
Compilation of cancer-associated genes.
A list of a total of 624 candidate cancer-associated genes was compiled using 11 sources, including recently published large-scale cancer studies, publicly available screening panels and analysis of publicly available data sources (Supplementary Table 6 ). The 204 genes shared across at least two of the nine sources were retained and a literature search was conducted to identify evidence supporting inclusion of any remaining unique genes. A subset of 518 genes originated from recent publications, including 294 genes from Frampton et al. 24 , 125 genes from Kandoth et al. 26 , 212 genes from Lawrence et al. 27 , 194 genes from Pritchard et al. 28 , 124 genes from Vogelstein et al. 31 , 48 genes from Rahman et al. 29 and 48 genes from Kanchi et al. 25 . Thirty-nine additional genes were included based on the analysis of driver mutations in 20 TCGA cancer types (Supplementary Table 6 ), recommendations in accordance with the standards and guidelines of the American College of Genetics and Genomics 30 and 18 novel cancer-driver genes identified in recently published large-scale studies.
Complex indel discovery and filtering procedure. Our analysis of variants from a standard genome reference sequence (HuRef GCA_000002125.2) genome indicates that a substantial number are complex (having both insertions and deletions) and are routinely missed by NGS data indel callers. A survey of the Catalog of Somatic Mutations in Cancer (COSMIC) and the NCBI short genetic variations dbSNP databases further suggests that complex indels are vastly under-represented. To address this issue, we developed Pindel-C to specifically search for co-occurring insertion and deletion events, i.e., 'complex indels' (Fig. 1) . The key elements and procedures of Pindel-C are the following. (i) Read extraction: all read pairs with one end spanning potential variant breakpoints are detected and extracted from a single alignment BAM file or multiple files. The alignment signals for read selection include soft-clip, gap alignment, unmapped and other non-M characters in the CIGAR string. For mates of these reads, we require mapping quality to exceed a user specified cutoff (30) and use their 3′ mapping positions as anchors for local mapping.
(ii) Pattern growth-based alignment: we align one base at a time from both terminals of the reads to both DNA strands around the 3′ end of the anchor read within two insert-size distances. Pattern growth [33] [34] [35] is used for string matching to search for the maximum unique substring between the read sequence and the local reference genome. (iii) Distinguishing complex indels from simple indels: a 'simple' event is inferred if the maximum unique substrings from two terminals of the read are able to cover the entire read or reference. Otherwise, if these substrings do not cover a segment inside the read and the reference, then we have likely detected a 'complex' event. To characterize potential complex indels, we left-shift the mapping position and then sort reads accordingly. If a set of reads has the same left and right mapping positions and the identical middle unmapped fragment, we combine them and report them as a potential complex indel. (iv) Removal of false predictions and analysis of variant-allele fraction: the strands of the supporting reads are examined to make sure that each strand is represented. Based on the predicted complex variant, we create a reference contig, including 10-kb flanks both upstream and downstream of the variant, as well as a complex indel-containing contig with the same setting. We then extract all reads within a 2-kb window of the variant position and remap them using BWA to the two contigs generated. Mapped reads with mapping quality of at least 30 are used for read-count analysis. The calculated coverage values are noted as the numbers of reads supporting reference or variant alleles. Since part of the read is not aligned to the reference genome, we expect a higher falsepositive rate in the raw calls because of various sequence artifacts, and we may perform additional manual inspections using IGV 22 . For example, we anticipate situations such as extensive soft-clipped reads without consistent breakpoints, reads with a 1-bp indel at a fixed read position unrelated to genomic position and sequence artifacts in nearby sequences. We discard the calls if any of the npg situations above are detected. The entire procedure has been automated and the scripts are available at https://github.com/ding-lab/VariantQC.
Identification of complex indels in cancer genes. The initial set of somatic complex indels in cancer genes contain 1,367 predictions if we require at least one supporting read from either strand and a VAF of at least 5%. Then we manually examine the supporting evidence using Integrated Genomic Viewer (IGV) 22 and also re-examine the numbers of reads supporting either allele using indel-containing contig-based mapping. For each detected complex indel, we first construct a reference-allele contig by including both the upstream and downstream 10-kb sequences (i.e., a 20-kb 'window'), as well as the reference allele as the reference allele. We then substitute the reference allele with the detected alternative allele. This gives us two contigs representing the alleles. We next extract all reads mapped within a 2-kb distance to the allele position. We remap those extracted reads using BWA paired-end mapping mode with parameter of -q 5. Finally we count the numbers of reads with more than a given mapping quality (30 by default) and mapped to each contig in the center of the 20-kb window. Based on the new read counts, we computed variantallele fraction and discarded any calls with VAF smaller than 0.05. We took the candidate sites as input and reran Pindel-C to identify tumor samples carrying the same somatic variation but which we missed in our discovery phase due to a low number of support reads.
Geometric probability test of proximity of 83 complex indels. We found that 83 of 285 complex indels were within 100 bp of another, suggesting nonrandom distribution. This observation was tested against a null hypothesis that these 285 instances are randomly distributed across the genome, by using a simple geometric probability model. Consider the a priori placement of one of these events at an arbitrary position and the random chance of another event being placed within 100 on either side of the first event. Assuming a conservative 30-Mb exome, the Bernoulli probability of any one of the remaining 284 events is 200 / (3 × 10 7 ), implying that the probability that one of them from the set will be within 100 bp of the trial event is 284 × 200 × exp (−200 × 283 / (3 × 10 7 )) / (3 × 10 7 ) ≈ 0.00189. The probability that 83 of these events participate in such proximity arrangements is appreciably smaller, suggesting that we reject the null hypothesis of random distribution.
Statistical test on complex indel VAF versus other simple variant VAF.
We assessed whether complex indel VAFs in specific gene-cancer combinations were statistically higher than their corresponding simple indels in the same samples using permutation testing. This type of test is 'data driven' in that the null distribution is constructed directly from the case-control data. An important aspect of such tests is that the size of the sample space determines the lowest attainable P value for any test. In fact, the lowest value is the inverse of the number of relevant combinations of the pooled tumor sample-control observations. We excluded from testing those cancer-gene combinations that could not, in principle, attain a minimal P value significance of 1%. This exclusion criterion eliminated essentially all single-sample combinations, as there is only an average of five simple indels per complex indel in each sample, and this left six cancer-gene combinations that were found to occur in between 3 and 11 individual samples. Five of these combinations had computational sample spaces small enough to permit full permutation testing. The sixth, EGFR in LUAD, had much more data with a consequent sample space size on the order of 10 12 . Here we performed a sampling-based permutation test rather than a full test by using 10 8 points of data selected randomly with replacement. The final list of P values was corrected for multiple-test effects by computing the standard Benjamini-Hochberg FDR.
Hypothesis testing of in-frame complex indels. We first estimated the Bernoulli probability, P F , of any single event being in frame by examining the size distribution of T = 1,680 exome-wide complex indels. These are taken as the 'background' information. Defining t(k) as the tally of indels of length k, the Bernoulli value is the conditional
where P(F | k) is 1 when k is any multiple of 3, otherwise it is 0. We found P F ≈ 0.103, meaning any single event is somewhat unlikely to be in frame. Under the null hypothesis, the chances that k of a group of N complex indels that occur independently of one another are in frame can then be described by the binomial distribution B(N, k, P F ). We parsed our complex indel data set, applying the binomial test to any grouping of at least seven events, of which at least two were in frame. These minimal cutoffs excluded the numerous low-information tumor samples that have only a few events, almost all of which were frameshifts. Once the tailed P values were computed, we applied the standard Benjamini-Hochberg FDR correction for multiple tests. We did not perform any testing for the converse phenomenon, i.e., in which numbers of frameshift mutations are higher than that explainable by chance. Because P F is so one-sided, our data set lacks the power to discern any groupings where this might be true. This is illustrated by a hypothetical group, all of whose events are frameshifts. The size of this group necessary to realize a P value of even 1% is the solution of (1 − P F ) N = 0.01, or about N = 43, which is substantially larger than any of the actual groupings in our data set.
